Terms: = Skin cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
4588 results:
1. Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review.
Patel S; Armbruster H; Pardo G; Archambeau B; Kim NH; Jeter J; Wu R; Kendra K; Contreras CM; Spaccarelli N; Dulmage B; Pootrakul L; Carr DR; Verschraegen C
PLoS One; 2024; 19(4):e0297531. PubMed ID: 38687774
[TBL] [Abstract] [Full Text] [Related]
2. Dermoscopic-Guided Shave Removal of Acquired Facial Melanocytic Nevi in Dark-skinned Individuals.
Rezk AF; Touni AA
Dermatol Surg; 2024 May; 50(5):434-438. PubMed ID: 38662517
[TBL] [Abstract] [Full Text] [Related]
3. skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract] [Full Text] [Related]
4. Clinical determinants of clinical response to Sonidegib in advanced basal cell carcinoma: a monocenter experience.
Spallone G; Carbone A; Sperati F; Frascione P; Eibenschutz L
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2923-2928. PubMed ID: 38639529
[TBL] [Abstract] [Full Text] [Related]
5. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
Chavez-Tapia NC; Sanchez-Jimenez BA; Vidaña-Perez D; Corrales-Rosas B; Balderas-Garces B; Vera-Izaguirre D; Santa Cruz FJ; Maldonado-Garcia C; Juarez-Hernandez E; Uribe M
PLoS One; 2024; 19(4):e0290632. PubMed ID: 38626012
[TBL] [Abstract] [Full Text] [Related]
6. Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
Matthies L; Amir-Kabirian H; Gebrekidan MT; Braeuer AS; Speth US; Smeets R; Hagel C; Gosau M; Knipfer C; Friedrich RE
PLoS One; 2024; 19(4):e0302017. PubMed ID: 38603731
[TBL] [Abstract] [Full Text] [Related]
7. Molecular patterns of resistance to immune checkpoint blockade in melanoma.
Lauss M; Phung B; Borch TH; Harbst K; Kaminska K; Ebbesson A; Hedenfalk I; Yuan J; Nielsen K; Ingvar C; Carneiro A; Isaksson K; Pietras K; Svane IM; Donia M; Jönsson G
Nat Commun; 2024 Apr; 15(1):3075. PubMed ID: 38594286
[TBL] [Abstract] [Full Text] [Related]
8. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.
Schaverien MV; Singh P; Smith BD; Qiao W; Akay CL; Bloom ES; Chavez-MacGregor M; Chu CK; Clemens MW; Colen JS; Ehlers RA; Hwang RF; Joyner MM; Largo RD; Mericli AF; Mitchell MP; Shuck JW; Tamirisa N; Tripathy D; Villa MT; Woodward WA; Zacharia R; Kuerer HM; Hoffman KE
JAMA Netw Open; 2024 Apr; 7(4):e245217. PubMed ID: 38578640
[TBL] [Abstract] [Full Text] [Related]
9. Intravascular large B-cell lymphoma of the eye: Literature review and new findings.
Roditi E; Panicker S; Fung AT
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100053. PubMed ID: 38556129
[TBL] [Abstract] [Full Text] [Related]
10. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal skin Electron Therapy.
Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
[TBL] [Abstract] [Full Text] [Related]
11. Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
Stavi V; Khaire N; Lipton JH; Kumar R
Curr Oncol; 2024 Feb; 31(3):1246-1252. PubMed ID: 38534926
[TBL] [Abstract] [Full Text] [Related]
12. Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
Yokota K; Takenouchi T; Fujisawa Y; Fukushima S; Uchi H; Inozume T; Kiyohara Y; Uhara H; Nakagawa K; Furukawa H; Han S; Watanabe M; Noguchi K; Yamazaki N
J Dermatol; 2024 May; 51(5):632-642. PubMed ID: 38529706
[TBL] [Abstract] [Full Text] [Related]
13. Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
Stark L; Kasajima A; Stögbauer F; Schmidl B; Rinecker J; Holzmann K; Färber S; Pfarr N; Steiger K; Wollenberg B; Ruland J; Winter C; Wirth M
Clin Epigenetics; 2024 Mar; 16(1):47. PubMed ID: 38528631
[TBL] [Abstract] [Full Text] [Related]
14. Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.
Holmstroem RB; Pedersen S; Jurlander R; Madsen K; Donia M; Ruhlmann CH; Schmidt H; Haslund CA; Bastholt L; Svane IM; Ellebaek E
Eur J Cancer; 2024 May; 202():114023. PubMed ID: 38518533
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract] [Full Text] [Related]
16. The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.
Kopecký J; Pásek M; Lakomý R; Melichar B; Mrazová I; Kubeček O; Arenbergerová M; Lemstrová R; Švancarová A; Tretera V; Hlodáková A; Žváčková K
Cancer Med; 2024 Mar; 13(5):e6982. PubMed ID: 38491825
[TBL] [Abstract] [Full Text] [Related]
17. Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma.
Albrecht LJ; Dimitriou F; Grover P; Hassel JC; Erdmann M; Forschner A; Johnson DB; Váraljai R; Lodde G; Placke JM; Krefting F; Zaremba A; Ugurel S; Roesch A; Schulz C; Berking C; Pöttgen C; Menzies AM; Long GV; Dummer R; Livingstone E; Schadendorf D; Zimmer L
Eur J Cancer; 2024 May; 202():113976. PubMed ID: 38484692
[TBL] [Abstract] [Full Text] [Related]
18. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
Shelton J; Zotow E; Smith L; Johnson SA; Thomson CS; Ahmad A; Murdock L; Nagarwalla D; Forman D
BMJ; 2024 Mar; 384():e076962. PubMed ID: 38479774
[TBL] [Abstract] [Full Text] [Related]
19. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
20. Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D.
Piotrowska A; Nowak JI; Wierzbicka JM; Domżalski P; Górska-Arcisz M; Sądej R; Popiel D; Wieczorek M; Żmijewski MA
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473753
[TBL] [Abstract] [Full Text] [Related]
[Next]
